Harrow Health, Inc. (HROW) vs Kardigan, Inc. (KARD)
A side-by-side comparison of Harrow Health, Inc. and Kardigan, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HROW
Harrow Health, Inc.
$30.48HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
KARD
Kardigan, Inc.
$14.02HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — HROW vs KARD
growth of $100 · dividends reinvested · last 1yHROW -18.8% (-18.8%/yr)KARD -30.7% (-30.7%/yr)HROW compounded faster over this window
HROW KARD
HROW vs KARD: by the numbers
- •KARD is the larger company ($1.25B vs $1.14B market cap).
- •Both run net losses; KARD's is the smaller (0.00% vs -13.51% net margin).
Metrics side by side
Valuation
| Metric | HROW | KARD |
|---|---|---|
| P/S ratio | 4.12 | N/A |
| P/B ratio | 74.75 | 2.03 |
| FCF yield | 0.47% | N/A |
Profitability
| Metric | HROW | KARD |
|---|---|---|
| Gross margin | 73.28% | 0.00% |
| Operating margin | 14.18% | 0.00% |
| Net margin | -13.51% | 0.00% |
| ROE | -244.91% | N/A |
| ROIC | 1.81% | -57.11% |
Growth (annualized)
| Metric | HROW | KARD |
|---|---|---|
| Revenue CAGR (5Y) | 34.52% | N/A |
| Total return CAGR (5Y) | 27.66% | N/A |
Go deeper
Dig into the metrics
Harrow Health ROEKardigan ROEHarrow Health operating marginKardigan operating marginHarrow Health revenue growthKardigan revenue growthHarrow Health free cash flowKardigan free cash flow
Harrow Health & Kardigan appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.